Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

FBIOX vs FBTAX overlap: 52% of top holdings shared

Bottom line

How much do FBIOX and FBTAX overlap?

52% of their top holdings overlap by weight. 13 securities appear in both funds' top 25, making up 40.4% of FBIOX's assets and 49.4% of FBTAX's. They share a meaningful core but differ in the rest of the portfolio.

Updated Nov 22, 2026

Overlap at a glance

FBIOXFBTAX
Weight overlap (top 25)52%
Shared holdings13
Weight in shared holdings40.4%49.4%
Total positions215129
Expense ratio0.62%0.94%
Holdings as ofMay 31, 2026Jul 31, 2026

Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)

Holdings FBIOX and FBTAX have in common

Holding% of FBIOX% of FBTAXOverlap
Abbvie Inc9.22%14.71%9.22%
Amgen Inc6.53%2.37%2.37%
Gilead Sciences Inc4.82%5.70%4.82%
Fidelity Revere Street Trust3.35%1.96%1.96%
Alnylam Pharmaceuticals Inc2.93%3.62%2.93%
Insmed Inc2.25%3.05%2.25%
Argenx Se2.25%3.00%2.25%
Ascendis Pharma A/s2.04%2.99%2.04%
Revolution Medicines Inc2.02%3.00%2.02%
Natera Inc1.41%1.43%1.41%
Moderna Inc1.28%1.60%1.28%
Biogen Inc1.26%2.71%1.26%
Cogent Biosciences Inc1.07%3.25%1.07%

Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in FBIOX

  1. Krystal Biotech Inc — 10.58%
  2. Praxis Precision Medicines Inc. — 2.47%
  3. Ucb Sa — 2.00%
  4. Jazz Pharmaceuticals Plc — 1.84%
  5. Scholar Rock Holding Corp — 1.55%
  6. Axsome Therapeutics Inc — 1.28%
  7. Protagonist Therapeutics Inc — 1.15%
  8. Roivant Sciences Ltd — 1.13%
  9. Tango Therapeutics Inc — 0.98%
  10. Celcuity Inc — 0.95%
  11. Madrigal Pharmaceuticals Inc — 0.93%
  12. Bridgebio Pharma Inc — 0.89%

Only in FBTAX

  1. Spyre Therapeutics Inc — 3.83%
  2. Dianthus Therapeutics Inc — 3.55%
  3. Oruka Therapeutics Inc — 3.24%
  4. Mbx Biosciences Inc — 2.45%
  5. Amylyx Pharmaceuticals Inc — 2.25%
  6. Vaxcyte Inc — 1.97%
  7. Relay Therapeutics Inc — 1.58%
  8. Viridian Therapeutics Inc — 1.53%
  9. Kiniksa Pharmaceuticals International Plc — 1.41%
  10. Vertex Pharmaceuticals Inc — 1.39%
  11. Enliven Therapeutics Inc — 1.25%
  12. Alumis Inc — 1.22%

Asset mix

Asset typeFBIOXFBTAX
Stocks99.0%98.2%
Cash & short-term funds3.5%2.4%
Preferred stock0.9%1.5%
Bonds—0.1%

Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)

Country mix

CountryFBIOXFBTAX
US88.5%87.8%
NL2.9%4.3%
DK2.6%3.0%
BE2.0%0.4%
IE2.0%—
KY0.6%1.8%
GB0.8%1.8%
CA0.4%1.4%

Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)

Check another pair

FAQ

How much do FBIOX and FBTAX overlap?
About 52% by weight. 13 securities appear in both funds' top 25 holdings; they make up 40.4% of FBIOX's assets and 49.4% of FBTAX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do FBIOX and FBTAX have in common?
The largest shared holdings are Abbvie Inc, Gilead Sciences Inc, Alnylam Pharmaceuticals Inc, Amgen Inc, Insmed Inc.
Should I own both FBIOX and FBTAX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, FBIOX or FBTAX?
FBIOX is broader, with 215 positions versus 129 for FBTAX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.